PATH
Menu

This study evaluated the performance of PATH’s rapid diagnostic assay detecting histidine rich protein 2 (HRP-2) antigen when used by local health care providers in a rural field setting in Lao PDR and examined rapid diagnostic assays as a strategy to identify participants for in vivo treatment trials in a rural field site.

Author(s): Labbé AC, Pillai DR, Hongvangthong B, et al

Corporate author(s): PATH; University of Toronto; Institute of Malariology, Parasitology, and Entomology, Lao PDR

Publication date: January 1999

Available materials

English

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Global

See also:

Emerging and epidemic diseasesMalaria

Health technologiesDiagnostic technologies

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA